TY - JOUR
T1 - Phenotypic and molecular character rization of nosocomial K. pneumoniae isolates by ribotyping
AU - Ahmad, Shamweel
AU - Abulhamd, Ashraf
N1 - Publisher Copyright:
© 2014 Published by Elsevier Urban &Partner Sp. z o.o. on behalf of Medical University of Bialystok.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Purpose: To characterize clinical isolates of Klebsiella pneumoniae by phenotypic and genotypic methods. Material/methods: Over a 12-month period, 52 isolates of K. pneumoniae were isolated. Of these 52 isolates, 7 were isolated over a period of 21 days from a suspected outbreak in the Neonatal Intensive Care Unit (NICU) and 45 from sporadic cases occurring in different wards of hospital were analysed. Results: The prevalence of K. pneumoniae isolates was 4% (52/1295). Quinolones, aztreonam and amikacin showed the greatest efficacy showing <85% sensitivity. Of the 52 isolates of K. pneumoniae, 8 (15.4%) isolates were positive for ESBL-production. Among the ESBL-producing K. pneumoniae, two out of 8 (25%) and 6 out of 8 (75%) were positive for blaSHV and blaCTX-M genes respectively. Ribotyping identified 30 distinct ribogroups among 52 isolates evaluated. Seven NICU outbreak isolates were divided into 2 ribotypes, as many as 6 belonged to one ribotype while one isolate which was isolated a week later was of a different ribotype, indicating the termination of the outbreak in the NICU. The outbreak in the NICU thus, was shown to have been caused by a single clone. Conclusions: A high discriminatory power, ease of interpretation coupled with excellent reproducibility and stability make ribotyping a very useful technique for investigating the molecular epidemiology of nosocomial infections caused by K. pneumoniae. A regular surveillance of hospital associated infections including monitoring antibiotic sensitivity pattern of K. pneumoniae, ESBL-production and molecular characterization is mandatory to control the spread of multidrug-resistant and ESBL-producing K. pneumoniae and for epidemiological purposes especially in outbreak situations.
AB - Purpose: To characterize clinical isolates of Klebsiella pneumoniae by phenotypic and genotypic methods. Material/methods: Over a 12-month period, 52 isolates of K. pneumoniae were isolated. Of these 52 isolates, 7 were isolated over a period of 21 days from a suspected outbreak in the Neonatal Intensive Care Unit (NICU) and 45 from sporadic cases occurring in different wards of hospital were analysed. Results: The prevalence of K. pneumoniae isolates was 4% (52/1295). Quinolones, aztreonam and amikacin showed the greatest efficacy showing <85% sensitivity. Of the 52 isolates of K. pneumoniae, 8 (15.4%) isolates were positive for ESBL-production. Among the ESBL-producing K. pneumoniae, two out of 8 (25%) and 6 out of 8 (75%) were positive for blaSHV and blaCTX-M genes respectively. Ribotyping identified 30 distinct ribogroups among 52 isolates evaluated. Seven NICU outbreak isolates were divided into 2 ribotypes, as many as 6 belonged to one ribotype while one isolate which was isolated a week later was of a different ribotype, indicating the termination of the outbreak in the NICU. The outbreak in the NICU thus, was shown to have been caused by a single clone. Conclusions: A high discriminatory power, ease of interpretation coupled with excellent reproducibility and stability make ribotyping a very useful technique for investigating the molecular epidemiology of nosocomial infections caused by K. pneumoniae. A regular surveillance of hospital associated infections including monitoring antibiotic sensitivity pattern of K. pneumoniae, ESBL-production and molecular characterization is mandatory to control the spread of multidrug-resistant and ESBL-producing K. pneumoniae and for epidemiological purposes especially in outbreak situations.
KW - blaSHV blaCTX-M Ribotyping
KW - K. pneumoniae
KW - Multidrug resistance ESBL
KW - Production Multiplex PCR
UR - http://www.scopus.com/inward/record.url?scp=84927712619&partnerID=8YFLogxK
U2 - 10.1016/j.advms.2014.10.003
DO - 10.1016/j.advms.2014.10.003
M3 - Article
C2 - 25500248
AN - SCOPUS:84927712619
SN - 1896-1126
VL - 60
SP - 69
EP - 75
JO - Advances in Medical Sciences
JF - Advances in Medical Sciences
IS - 1
ER -